Immunotherapy vs chemotherapy in Lucknow explained by Dr. N. A. SiddiquiChemotherapy directly targets rapidly growing cancer cells, while immunotherapy helps the immune system fight cancer. The right treatment depends on cancer type, stage and biomarkers.

Immunotherapy vs Chemotherapy in Lucknow: Which Is Better?

Cancer treatment has changed significantly over the last several years.

While chemotherapy remains one of the most important treatments for many cancers, immunotherapy has created new treatment possibilities for selected patients.

Therefore, one of the most common questions patients and families ask is:

“Which is better—immunotherapy or chemotherapy?”

The answer is not the same for every patient.

Chemotherapy and immunotherapy work in very different ways. Moreover, some cancers respond better to chemotherapy, some may benefit from immunotherapy, and in several situations doctors may recommend both treatments together.

The correct treatment depends on:

  • Cancer type
  • Cancer stage
  • Biopsy and pathology
  • Biomarker results
  • Molecular profile
  • Previous cancer treatment
  • General health
  • Expected benefits
  • Possible side effects

The National Cancer Institute explains that chemotherapy works by killing or stopping the growth of rapidly growing cells, while immunotherapy helps the immune system fight cancer.

Patients considering either treatment can read more about Immunotherapy for Cancer in Lucknow and Chemotherapy in Lucknow.

What Is Chemotherapy?

Chemotherapy uses anti-cancer medicines that can travel through the bloodstream and act on cancer cells throughout the body.

It mainly works by killing cancer cells or stopping rapidly growing cells from dividing.

Depending on the cancer, chemotherapy may be used:

  • Before surgery
  • After surgery
  • Alongside radiation
  • As the main cancer treatment
  • For recurrent cancer
  • For metastatic or Stage 4 cancer
  • To reduce cancer-related symptoms

For example, chemotherapy given before surgery is called neoadjuvant chemotherapy.

In contrast, chemotherapy given after surgery to reduce the risk of cancer returning may be called adjuvant chemotherapy.

If you are considering chemotherapy locally, see Chemotherapy Treatment in Lucknow – Dr. N. A. Siddiqui.

What Is Immunotherapy?

Immunotherapy is a cancer treatment that helps the body’s immune system recognize or attack cancer more effectively.

Normally, the immune system can identify many abnormal cells. However, cancer cells can sometimes develop ways to escape or suppress immune responses.

Therefore, some immunotherapy medicines work by removing these immune “brakes,” allowing immune cells to respond more effectively against cancer.

One important group of immunotherapy medicines is known as immune checkpoint inhibitors.

These may target immune pathways involving proteins such as:

  • PD-1
  • PD-L1
  • CTLA-4

However, immunotherapy is not appropriate for every cancer or every patient.

For detailed information, visit Immunotherapy for Cancer in Lucknow – Dr. N. A. Siddiqui.

Immunotherapy vs Chemotherapy: What Is the Main Difference?

The major difference is how each treatment fights cancer.

FeatureChemotherapyImmunotherapy
Main actionDirectly damages or kills rapidly growing cancer cellsHelps the immune system recognize or attack cancer
Treatment selectionMainly based on cancer type, stage and regimenOften depends on cancer type, stage and sometimes biomarkers
Hair lossCan occur with certain chemotherapy drugsLess typical with checkpoint immunotherapy alone
Blood countsMay reduce white cells, hemoglobin or plateletsLess commonly causes classic bone-marrow suppression
Key side effectsNausea, fatigue, low blood counts, hair loss, neuropathy, mouth soresRash, diarrhea, thyroid problems and immune inflammation of organs
Can they be combined?YesYes, in selected cancers

Importantly, this table describes broad differences.

Individual medicines can behave differently, and each patient requires personalized assessment.

Is Immunotherapy Better Than Chemotherapy?

Not universally.

It is incorrect to assume that immunotherapy is always a newer and therefore better treatment.

For some cancers, chemotherapy remains essential.

For others, immunotherapy may provide substantial benefit in appropriately selected patients.

Furthermore, some cancers are treated most effectively using a combination of chemotherapy and immunotherapy.

Dr. Siddiqui’s current immunotherapy service information similarly notes that neither treatment is universally better and that treatment selection depends on the diagnosis and individual clinical situation.

Therefore, the better question is:

“Which treatment has the strongest evidence for my exact cancer?”

Which Cancers May Be Treated With Immunotherapy?

Immunotherapy has become important in selected patients with cancers such as:

  • Lung cancer
  • Melanoma
  • Kidney cancer
  • Bladder cancer
  • Head and neck cancer
  • Esophageal cancer
  • Stomach cancer
  • Liver cancer
  • Cervical cancer
  • Triple-negative breast cancer in selected situations
  • Certain colorectal cancers
  • Hodgkin lymphoma
  • Other biomarker-selected cancers

However, the exact indication differs according to cancer subtype, stage and treatment setting.

NCI also emphasizes that although immunotherapy is approved for many cancers, it is not as broadly applicable to every tumor as conventional treatments such as chemotherapy.

Which Cancers Are Commonly Treated With Chemotherapy?

Chemotherapy is used in many different solid tumors and blood cancers.

Depending on the situation, it may be part of treatment for:

  • Breast cancer
  • Lung cancer
  • Ovarian cancer
  • Colon and rectal cancer
  • Stomach cancer
  • Pancreatic cancer
  • Head and neck cancer
  • Testicular cancer
  • Lymphoma
  • Leukemia
  • Multiple myeloma
  • Several other cancers

Nevertheless, the exact chemotherapy medicines used for one cancer may be completely different from those used for another.

Therefore, there is no universal “cancer chemotherapy.”

Why Is Biomarker Testing Important Before Immunotherapy?

This is one of the most important differences between modern immunotherapy and traditional chemotherapy.

For selected cancers, doctors may use biomarker testing to help determine whether a patient is likely to benefit from a particular treatment.

Possible biomarkers may include:

  • PD-L1
  • MSI
  • MMR
  • Tumor Mutational Burden
  • Other disease-specific molecular findings

NCI explains that biomarker testing looks for genes, proteins or other features of cancer that can help guide treatment, and some immunotherapies work only for cancers with particular biomarkers.

However, a positive biomarker does not guarantee that treatment will work.

Similarly, not every cancer requires the same biomarker testing.

Therefore, testing needs to be selected according to the specific cancer.

For patients who require molecular and diagnostic evaluation, see Cancer Tests & Diagnosis in Lucknow.

Does Every Patient Need PD-L1 Testing?

No.

PD-L1 is useful in certain cancer-treatment decisions, but its importance differs between diseases.

For example, PD-L1 may influence immunotherapy selection in some lung, head-and-neck and other cancers.

However, treatment decisions may also depend on:

  • Cancer stage
  • Histology
  • Other biomarkers
  • Previous therapies
  • Combination-treatment strategy
  • Current treatment guidelines

Therefore, PD-L1 should never be interpreted in isolation.

Can Chemotherapy and Immunotherapy Be Given Together?

Yes.

This is increasingly common in selected cancers.

For example, chemo-immunotherapy combinations may be considered for selected cases of:

  • Lung cancer
  • Triple-negative breast cancer
  • Stomach cancer
  • Esophageal cancer
  • Head and neck cancer
  • Cervical cancer
  • Other cancers depending on current evidence

The user’s existing immunotherapy service page also describes combined chemotherapy and immunotherapy as an option in selected cancers.

Therefore, the question is not always:

“Chemotherapy or immunotherapy?”

Sometimes the correct strategy is:

“Chemotherapy plus immunotherapy.”

Why Combine Immunotherapy With Chemotherapy?

The two treatments work differently.

Chemotherapy can directly damage cancer cells.

Meanwhile, immunotherapy can enhance the immune response against cancer.

Therefore, combining them can sometimes improve treatment effectiveness in selected disease settings.

However, combination treatment may also increase treatment burden and side effects.

Consequently, it should only be used when there is evidence that the potential benefit justifies the additional treatment.

Chemotherapy Side Effects

Chemotherapy side effects depend on the exact drugs being used.

Possible effects include:

  • Nausea
  • Vomiting
  • Fatigue
  • Hair loss
  • Mouth sores
  • Reduced appetite
  • Low white blood cells
  • Infection risk
  • Anemia
  • Low platelets
  • Diarrhea
  • Constipation
  • Peripheral neuropathy

However, not every chemotherapy drug causes all of these problems.

Furthermore, supportive medicines can significantly reduce some side effects.

For example, modern anti-nausea medicines can help control chemotherapy-related nausea and vomiting.

Patients can read the detailed guide: Chemotherapy Side Effects and How to Manage Them on the blog.

Immunotherapy Side Effects

Immunotherapy has a different side-effect profile.

Because treatment activates or modifies immune responses, the immune system may sometimes attack healthy tissues.

Possible immune-related side effects can involve:

  • Skin
  • Bowel
  • Thyroid
  • Liver
  • Lungs
  • Hormone-producing glands
  • Other organs

Symptoms may include:

  • Rash
  • Itching
  • Diarrhea
  • Fatigue
  • Cough
  • Breathlessness
  • Thyroid problems
  • Liver inflammation
  • Colitis
  • Pneumonitis
  • Hormonal changes

NCI notes that immunotherapy side effects can occur when an activated immune system attacks healthy tissues, and these problems may occur during or even after treatment.

Therefore, new symptoms during immunotherapy should be reported early.

Is Immunotherapy Easier Than Chemotherapy?

Sometimes, but not always.

Many patients receiving checkpoint immunotherapy may have fewer traditional chemotherapy-type effects such as severe nausea or hair loss.

However, this does not mean immunotherapy has no serious risks.

Immune-related inflammation can occasionally affect important organs.

For example:

  • Pneumonitis affects the lungs
  • Colitis affects the bowel
  • Hepatitis affects the liver
  • Thyroiditis affects the thyroid
  • Other endocrine glands can also be affected

Therefore, immunotherapy requires regular clinical monitoring.

Does Immunotherapy Cause Hair Loss?

Hair loss is generally less characteristic of checkpoint immunotherapy alone than of certain chemotherapy regimens.

However, individual responses vary.

Furthermore, if immunotherapy is combined with chemotherapy, hair loss may occur because of the chemotherapy component.

Therefore, patients should ask about the expected side effects of their exact regimen, rather than simply asking whether immunotherapy causes hair loss.

Does Chemotherapy Work Faster Than Immunotherapy?

In some cancers, chemotherapy can produce relatively rapid tumor shrinkage.

However, this cannot be used as a universal rule.

Different cancers and medicines behave differently.

Similarly, some patients respond quickly to immunotherapy, while others may take longer.

Therefore, treatment selection should not be based simply on which therapy is believed to “work faster.”

The urgency of disease control is only one factor among many.

Can Immunotherapy Produce Long-Lasting Responses?

Yes, in some patients.

One reason immunotherapy has changed cancer care is that selected patients can experience durable responses.

However, this does not occur in everyone.

Therefore, immunotherapy should not be presented as a guaranteed long-term solution.

Treatment benefit depends on the cancer type, disease biology and individual response.

Is Immunotherapy Used for Stage 4 Cancer?

Yes, for selected Stage 4 cancers.

For example, immunotherapy may be important in certain advanced:

  • Lung cancers
  • Kidney cancers
  • Bladder cancers
  • Melanomas
  • Head and neck cancers
  • Gastrointestinal cancers
  • Other selected tumors

However, not every Stage 4 patient needs immunotherapy.

Treatment may instead involve:

  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy
  • Combination treatment
  • Radiation
  • Supportive care

For more information, visit Stage 4 Cancer Treatment in Lucknow.

That page emphasizes that Stage 4 cancer does not have one standard treatment for every patient and that biomarker-guided therapy may influence treatment selection.

Immunotherapy vs Chemotherapy in Metastatic Cancer

Metastatic cancer means cancer has spread from its original location to a distant site.

In this setting, systemic treatments become particularly important.

Depending on the primary cancer, treatment may involve:

  • Chemotherapy
  • Immunotherapy
  • Targeted therapy
  • Hormone therapy
  • Combinations of treatments

Furthermore, biomarker testing is increasingly relevant in many metastatic cancers because it may identify actionable treatment options.

For detailed information, visit Metastatic Cancer Treatment in Lucknow.

Can Immunotherapy Replace Chemotherapy Completely?

Sometimes immunotherapy may be used without chemotherapy.

However, this depends on the cancer.

In other situations:

  • Chemotherapy remains essential
  • Immunotherapy is added to chemotherapy
  • Chemotherapy is used first
  • Immunotherapy is used after another treatment
  • Biomarker results determine the preferred strategy

Therefore, immunotherapy should not be viewed as a universal replacement for chemotherapy.

How Do Doctors Decide Between Immunotherapy and Chemotherapy?

Before recommending treatment, a medical oncologist may review:

  • Exact cancer diagnosis
  • Histopathology
  • Cancer stage
  • Sites of spread
  • Biomarker testing
  • Molecular findings
  • Previous treatment
  • General health
  • Autoimmune history
  • Kidney and liver function
  • Treatment goals

In many cases, accurate pathology and biomarker testing are essential before the treatment decision.

For this reason, Cancer Tests & Diagnosis in Lucknow explains that cancer diagnosis may include pathology, imaging and biomarker or molecular testing before individualized treatment is selected.

What If a Patient Has an Autoimmune Disease?

This is particularly relevant before immunotherapy.

Because immunotherapy activates immune pathways, a history of autoimmune disease may affect treatment decisions.

However, having an autoimmune condition does not automatically mean immunotherapy can never be used.

Instead, the oncologist must consider:

  • Type of autoimmune disease
  • Severity
  • Current medicines
  • Previous disease activity
  • Cancer treatment alternatives
  • Expected benefit from immunotherapy

Therefore, patients should tell their oncologist about all autoimmune diagnoses and medications before treatment.

How Is Treatment Response Checked?

Neither treatment should be judged purely by how the patient feels.

Doctors may monitor response using:

  • Clinical examination
  • Blood tests
  • CT scan
  • MRI
  • PET-CT in selected cancers
  • Tumor markers where useful
  • Symptoms
  • Performance status

Importantly, chemotherapy side effects do not necessarily mean treatment is working better.

Similarly, having few immunotherapy side effects does not mean immunotherapy is ineffective.

Treatment response must be assessed objectively.

Questions to Ask Before Choosing Treatment

Before starting treatment, consider asking your medical oncologist:

  1. What exact type of cancer do I have?
  2. What stage is it?
  3. What is the goal of treatment?
  4. Is chemotherapy recommended?
  5. Is immunotherapy an option?
  6. Do I need PD-L1 or other biomarker tests?
  7. Could targeted therapy be more appropriate?
  8. Should chemotherapy and immunotherapy be combined?
  9. What side effects should I watch for?
  10. How will treatment response be measured?
  11. What happens if the first treatment does not work?
  12. Is a second oncology opinion useful?

These questions can help patients understand why a particular treatment has been recommended.

Immunotherapy and Chemotherapy in Lucknow – Dr. N. A. Siddiqui

Dr. N. A. Siddiqui is a Consultant Medical Oncologist & Hematologist in Lucknow.

His qualifications include:

  • MBBS
  • MD (Medicine)
  • DNB (Medical Oncology)
  • MRCP (UK)
  • PDCR
  • Certificate in Immuno-Oncology
  • ESMO Certified Medical Oncologist

His medical-oncology practice includes evaluation and treatment planning involving:

  • Chemotherapy
  • Immunotherapy
  • Targeted therapy
  • Hormone therapy
  • Advanced and metastatic cancer care
  • Biomarker-guided treatment
  • Treatment monitoring
  • Supportive oncology care

For patients who may benefit from immune-based treatment, visit Immunotherapy for Cancer in Lucknow.

For chemotherapy-specific information, visit Chemotherapy in Lucknow.

Patients who need broader cancer-treatment planning can also visit Cancer Doctor in Lucknow – Dr. N. A. Siddiqui.

Nabeel Cancer Care Centre
529A/142, Sant Kabir Lane, In Front of Farabi Restaurant, Khurram Nagar, Lucknow – 226022
Appointment: +91 7860736600
Website: www.drnasiddiqui.in

Dr. Siddiqui’s current clinic website lists him as a Medical Oncologist in Lucknow and includes chemotherapy, immunotherapy and multiple cancer-specific treatment areas within his oncology practice.

Frequently Asked Questions

Is immunotherapy better than chemotherapy?

Not for every patient. Each treatment works differently, and the preferred option depends on cancer type, stage, biomarkers and other clinical factors.

What is the main difference between immunotherapy and chemotherapy?

Chemotherapy directly attacks rapidly growing cells. In contrast, immunotherapy helps the immune system fight cancer.

Can immunotherapy and chemotherapy be given together?

Yes. Selected cancers may be treated with chemo-immunotherapy combinations.

Does immunotherapy cause hair loss?

Hair loss is less typical with checkpoint immunotherapy alone than with certain chemotherapy regimens. However, hair loss may occur when immunotherapy is combined with chemotherapy.

Does everyone with cancer qualify for immunotherapy?

No. Immunotherapy is suitable only for selected cancers and patients. Cancer type, stage, biomarkers, previous treatments and general health may affect eligibility.

Is biomarker testing required before immunotherapy?

It is important in many clinical situations but not identical for every cancer. Tests such as PD-L1, MSI/MMR or other disease-specific biomarkers may influence treatment decisions.

What are common immunotherapy side effects?

Possible effects include fatigue, rash, diarrhea and immune-related inflammation involving organs such as the thyroid, liver, bowel or lungs.

What are common chemotherapy side effects?

Depending on the drugs, chemotherapy may cause nausea, fatigue, hair loss, low blood counts, infection risk, mouth sores, digestive symptoms or neuropathy.

Can Stage 4 cancer be treated with immunotherapy?

Yes, selected Stage 4 cancers can be treated with immunotherapy. However, it is not appropriate for every cancer or patient.

Can immunotherapy cure cancer?

Some patients can achieve long-lasting responses, but immunotherapy cannot be described as a guaranteed cure. The expected outcome depends on the cancer and individual response.

How do I know which treatment is right for me?

The decision should be based on pathology, stage, biomarkers, previous treatment, overall health and current evidence. A medical oncologist can interpret these factors together.

Where can I get immunotherapy or chemotherapy consultation in Lucknow?

Dr. N. A. Siddiqui provides medical-oncology consultation and individualized treatment planning at Nabeel Cancer Care Centre, Khurram Nagar, Lucknow.

Conclusion

Immunotherapy and chemotherapy are not competing treatments where one is always better than the other.

Instead, they are different tools used to treat cancer.

Chemotherapy directly attacks rapidly dividing cancer cells.

In contrast, immunotherapy helps the immune system identify or attack cancer.

Therefore, treatment may involve:

  • Chemotherapy alone
  • Immunotherapy alone
  • Chemotherapy plus immunotherapy
  • Targeted therapy
  • Hormone therapy
  • Other individualized treatment combinations

Most importantly, treatment should be selected according to the exact cancer type, stage, pathology and biomarker profile rather than simply choosing the newest therapy.

If you are comparing immunotherapy vs chemotherapy in Lucknow, an oncology consultation can help determine which approach—or combination—is most appropriate for your specific diagnosis.

Medical Disclaimer: This article is for general educational purposes only and does not replace individualized diagnosis or cancer-treatment advice. Immunotherapy and chemotherapy decisions vary substantially according to cancer type, stage, pathology, biomarkers, previous treatment and patient health.

Leave a Reply

Your email address will not be published. Required fields are marked *